Verrica Pharmaceuticals to Host Virtual KOL Event Discussing the Approval of YCANTH™ (Cantharidin) Topical Solution for the Treatment of Molluscum on October 11, 2023

<p>WEST CHESTER, Pa., Sept. 27, 2023 (GLOBE NEWSWIRE) &#8212; Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it will host a virtual KOL event discussing the approval of YCANTH™ (cantharidin) topical solution for the treatment of molluscum contagiosum on [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/verrica-pharmaceuticals-to-host-virtual-kol-event-discussing-the-approval-of-ycanth-cantharidin-topical-solution-for-the-treatment-of-molluscum-on-october-11-2023/">Verrica Pharmaceuticals to Host Virtual KOL Event Discussing the Approval of YCANTH™ (Cantharidin) Topical Solution for the Treatment of Molluscum on October 11, 2023</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>